Article citationsMore>>
I. Puzanov, J. A. Sosman, A. Santoro, R. E. Martell, G. K. Dy, L. Williams Goff, W. W. Ma, G. J. Fetterly, S. A. Michael, J. A. Means-Powell, F. Chai, M. Lamar, G. M. Strauss, P. A. Zucali, W. M. Chiang, J. Jarboe, B. E. Schwartz and A. A. Adjei, “Safety and Efficacy of MET Inhibitor Tivantinib (ARQ 197) Combined with Sorafenib in Patients (pts) with Renal Cell Carcinoma (RCC) from a Phase I Study,” Journal of Clinical Oncology, Vol. 30, 2012, Abstract No. 4545.
has been cited by the following article:
Related Articles:
-
Casimir Komenan
-
Appiya Ramamoorthy Balaji, Pritam Pritish Patnaik, Javangula Venkata Surya Prakash, Sattanathan Vetrichandar, Krishnan Vembu Arasi, Arun Kumar Paranjothi, Vetrivel Natarajan
-
Toshikazu Moriwaki, Tetsuya Eto, Akihito Tsuji, Nobushige Kakinoki, Mitsuo Shimada, Takashi Maeba, Hiroaki Hatano, Ikuo Takahashi, Hiroyasu Ishida, Kazuho Ikeda, Yoshiaki Bando, Ichinosuke Hyodo
-
Moawwad E. A. El-Mikkawy
-
Mohammad Reza Farahani, Wei Gao